Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Genome-wide knockout screen of OC43/SARS-CoV2-infected HEK293-hACE2 cells II

ABSTRACT: Genome-wide CRISPR screens identified host factors that promote human coronavirus infection, revealing novel antiviral drug targets.

ORGANISM(S): Homo sapiens

PROVIDER: GSE177543 | GEO | 2021/12/22

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Genome-wide knockout screen of OC43/SARS-CoV2-infected HEK293-hACE2 cells I

Project description:Genome-wide CRISPR screens identified host factors that promote human coronavirus infection, revealing novel antiviral drug targets.

2021-12-22 | GSE177537 | GEO

Genome-wide knockout screen of OC43/SARS-CoV2-infected Vero E6 cells

Project description:Genome-wide CRISPR screens identified host factors that promote human coronavirus infection, revealing novel antiviral drug targets.

2021-12-22 | GSE177541 | GEO

Genome-wide knockout screen of OC43/SARS-CoV2-infected HEK293-hACE2 and Vero E6 cells

Project description:This SuperSeries is composed of the SubSeries listed below.

2021-12-22 | GSE177545 | GEO

Genome-wide knockout screen of OC43/SARS-CoV2-infected HEK293-hACE2 cells I

Project description:Genome-wide knockout screen of OC43/SARS-CoV2-infected HEK293-hACE2 cells I

| PRJNA737125 | ENA

Genome-wide knockout screen of OC43/SARS-CoV2-infected HEK293-hACE2 cells II

Project description:Genome-wide knockout screen of OC43/SARS-CoV2-infected HEK293-hACE2 cells II

| PRJNA737127 | ENA

Genome-wide knockout screen of OC43/SARS-CoV2-infected HEK293-hACE2 and Vero E6 cells

Project description:Genome-wide knockout screen of OC43/SARS-CoV2-infected HEK293-hACE2 and Vero E6 cells

| PRJNA737123 | ENA

IL-9 exacerbates SARS-CoV2 infection and associated airway inflammation

Project description:Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus diseases 2019 (COVID-19) and broncho-alveolar inflammation (Merad and Martin, 2020). IL-9 induces airway inflammation and bronchial hyper responsiveness in respiratory viral illnesses and allergic inflammation (Temann et al., 1998). However, the role of IL-9 is not yet identified in SARS-CoV2 infection. Here we show that IL-9 promotes SARS-CoV2 infection and airway inflammation in K18-hACE2 transgenic (ACE2.Tg) mice, as IL-9 blockade reduces SARS-CoV2 infection and suppressed airway inflammation. Foxo1 is essential for the induction of IL-9 in helper T (Th) cells (Malik et al., 2017). While ACE2.Tg mice with Foxo1-deficiency in CD4+ T cells were performed to be resistant to SARS-CoV2 infection associated with reduced IL-9 production, exogenous IL-9 made Foxo1-deficient mice susceptible to SARS-CoV2 infection with increased airway inflammation. Collectively, we identify a mechanistic insight of IL-9-mediated regulation of antiviral and inflammatory pathways in SARS-CoV2 infection, and unravel a principle for the development of host-directed therapeutics to mitigate disease severity.

2022-07-22 | GSE209550 | GEO

Functional genomic screens in human cells to identify host factors for SARS-CoV-2 and common cold coronaviruses

Project description:We performed genome-wide CRISPR KO screens in human Huh7.5.1 cells to select for mutations that render host cells resistant to viral infection by SARS-CoV-2, human coronavirus 229E and OC43.

2020-10-16 | E-MTAB-9638 | biostudies-arrayexpress

bulk RNAseq of SARS-COV2 infected human lung organoid

Project description:Coronavirus disease 2019 (COVID-19) is the latest respiratory pandemic resulting from zoonotic transmission of severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2). Severe symptoms include viral pneumonia secondary to infection and inflammation of the lower respiratory tract, in some cases causing death. We developed primary human lung epithelial 5 infection models to understand responses of proximal and distal lung epithelium to SARS-CoV-2 infection. Differentiated air-liquid interface cultures of proximal airway epithelium and 3D organoid cultures of alveolar epithelium were readily infected by SARS-CoV-2 leading to an epithelial cell-autonomous proinflammatory response. We validated the efficacy of selected candidate COVID-19 drugs confirming that Remdesivir strongly suppressed viral 10 infection/replication. We provide a relevant platform for studying COVID-19 pathobiology and for rapid drug screening against SARS-CoV-2 and future emergent respiratory pathogens.

2020-11-06 | GSE160435 | GEO

Cepharanthine shows antiviral activities by modulating cellular stress responses triggered by a SARS-CoV2 related coronavirus

Project description:Antiviral therapies targeting the pandemic coronavirus disease 2019 (COVID 19) are urgently required. We studied an already approved botanical drug cepharanthine (CEP) in a cell culture model of GX_P2V, a severe acute respiratory syndrome coronavirus 2 (SARS CoV 2) related virus. RNA sequencing results showed the virus perturbed the expression of multiple cell stress responses such as endoplasmic reticulum (stress and HSF1 mediated heat shock response related genes and signaling pathways, of which heat shock response related genes and pathways were at the core. CEP was potent to reverse most dysregulated genes and pathways in infected cells mainly by interfering with cellular stress responses including ER stress unfolded protein response and HSF 1 mediated heat shock response . Additionally, single cell transcriptomes from COVID 19 patients (GSE150728 and GSE148829) also confirmed that cellular stress responses and stress induced autophagy play an important role in the development of COVID 19. In summary, this study uncovered the potential mechanisms of the anti-viral activities of CEP, providing evidence for CEP as a promising therapeutic option and modulating cellular stress could be a promising therapy for SARS CoV 2 infection.

2020-12-31 | GSE158050 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data